In malignant glioma cells, OLIG2/DLL3 and AQP4/CLU distinguish tumor cells exhibiting transcriptomic features of oligodendrocytes and astrocytes, respectively [17–19]. This evidence concerns the gene DLL3 and central nervous system cancer.